TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $678,305 | +54338.6% | 75,873 | -6.4% | 0.04% | -41.9% |
| Q2 2023 | $1,246 | -30.7% | 81,103 | +1.5% | 0.07% | -32.7% |
| Q1 2023 | $1,798 | +13.3% | 79,940 | +5.9% | 0.11% | +12.2% |
| Q4 2022 | $1,587 | -99.9% | 75,466 | +70.3% | 0.10% | +36.1% |
| Q3 2022 | $1,092,000 | -1.6% | 44,314 | -3.2% | 0.07% | +4.3% |
| Q2 2022 | $1,110,000 | +4.1% | 45,800 | +10.7% | 0.07% | +21.1% |
| Q1 2022 | $1,066,000 | +37.2% | 41,378 | +65.3% | 0.06% | +50.0% |
| Q4 2021 | $777,000 | – | 25,039 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
| Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
| Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
| GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
| ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
| HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
| MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
| Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
| Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |